Skip to main content
All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for CURIUM · Pharmaceutical manufacturing.

 Filing · LD-1 registration Registration
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jun 15, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Missouri

Official filing document

 Lobbyists on this filing 2
  • JOHN MARTIN New on this filing
    Previously held: Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton.
  • ANN JABLON New on this filing
    Previously held: Rep. Richard E. Neal; Legislative Director, Rep. Richard E. Neal; Administrative Assistant, Rep. Richard E. Neal; Executive/ Legislative Assistant, Rep. Richard E. Neal.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 1

Issues regarding radiopharmaceutical New Drug Application (NDA) approvals.

 Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

  • CAPVEST PARTNERS LLP
    United Kingdom · London · owns 100% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem